Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeuTigers has developed and commercialized Edge-AI solutions that enable early detection, screening, and continuous remote monitoring of chronic and rare diseases. Their technology integrates with wearables to provide real-time insights for proactive intervention in healthcare settings. The company has established partnerships with major industry players such as Samsung to co-develop exclusive health solutions.
No clinical trial results are reported as the company focuses on digital health platforms rather than therapeutics.
Their products are being adopted in multiple regions through strategic partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeuTigers.